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Abstract
Introduction: This systematic review and meta-analysis aimed to evaluate the effect of small bowel feeding
compared with gastric feeding on the frequency of pneumonia and other patient-important outcomes in critically
ill patients.
Methods: We searched EMBASE, MEDLINE, clinicaltrials.gov and personal files from 1980 to Dec 2012, and
conferences and proceedings from 1993 to Dec 2012 for randomized trials of adult critically ill patients in the
intensive care unit (ICU) comparing small bowel feeding to gastric feeding, and evaluating risk of pneumonia,
mortality, length of ICU stay, achievement of caloric requirements, duration of mechanical ventilation, vomiting,
and aspiration. Independently, in duplicate, we abstracted trial characteristics, outcomes and risk of bias.
Results: We included 19 trials with 1394 patients. Small bowel feeding compared to gastric feeding was associated
with reduced risk of pneumonia (risk ratio [RR] 0.70; 95% CI, 0.55, 0.90; P = 0.004; I2 = 0%) and ventilator-associated
pneumonia (RR 0.68; 95% CI 0.53, 0.89; P = 0.005; I2 = 0%), with no difference in mortality (RR 1.08; 95% CI 0.90,
1.29; P = 0.43; I2 = 0%), length of ICU stay (WMD -0.57; 95%CI -1.79, 0.66; P = 0.37; I2 = 0%), duration of mechanical
ventilation (WMD -1.01; 95%CI -3.37, 1.35; P = 0.40; I2 = 17%), gastrointestinal bleeding (RR 0.89; 95% CI 0.56, 1.42;
P = 0.64; I2 = 0%), aspiration (RR 0.92; 95% CI 0.52, 1.65; P = 0.79; I2 = 0%), and vomiting (RR 0.91; 95% CI 0.53, 1.54;
P = 0.72; I2 = 57%). The overall quality of evidence was low for pneumonia outcome.
Conclusions: Small bowel feeding, in comparison with gastric feeding, reduces the risk of pneumonia in critically
ill patients without affecting mortality, length of ICU stay or duration of mechanical ventilation. These observations
are limited by variation in pneumonia definition, imprecision, risk of bias and small sample size of individual trials.
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Introduction
Enteral nutrition delivery is the preferred optimal method
of nutritional supplement in patients in the ICU [1]. After
careful consideration of an individual patient’s illness
severity, level of physiologic stress, and baseline nutritional
status, early enteral feeding has been shown to attenuate
disease severity, maintain gastrointestinal (GI) physiology,
and modulate the immune system [2]. A meta-analysis of
randomized controlled trials (RCTs) suggested that early
enteral nutrition reduces infections when compared with
parenteral nutrition, although the results were limited by
the presence of heterogeneity and methodologic quality
individual trials [3]. However, enteral nutrition can be
associated with risk of aspiration, gastric and feeding intol-
erance, and issues surrounding tube placements [4].
Guidelines from the American Society of Parenteral and
Enteral Nutrition (ASPEN) recommend using enteral
nutrition when feasible [2]. Strategies to optimize the ben-
efits and minimize the risks of enteral nutrition include
early initiation, within 24 to 28 hours of admission if feasi-
ble, elevation of the head of the bed, use of motility agents,
minimizing narcotic dosages, and reevaluation of gastric
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residual amounts. Although the value of routine measure-
ment of gastric residual volume (GRV) in enterally fed cri-
tically ill patients has been challenged by a recent RCT [5],
the ASPEN guidelines recommend small bowel over gas-
tric feeding in patients with persistent high GRV [2].
It is not known if small bowel feeding is associated
with a lower risk of pneumonia in critically ill patients.
Multiple systematic reviews reached conflicting results
[6-9]. Recently, an RCT by Davies et al. that included
180 patients suggested that there is no difference in the
risk of ventilator-associated pneumonia (VAP) between
patients receiving gastric versus jejunal feeds [10]. At
the time of writing, this is the largest published RCT on
this topic.
In the view of unclear literature as well as presence of
new information we conducted an updated systematic
review and meta-analysis to examine the efficacy of
using small bowel feeding as opposed to gastric feeding
in critically ill patients.
Materials and methods
Search strategy
We searched EMBASE, MEDLINE from January 1980 to
December 2012, independently and in duplicate. Search
strategy is summarized in Additional file 1. We searched
clinicaltrials.gov, our personal files, and reference lists of
eligible studies and review articles for additional trials. Uti-
lizing a specialized search engine provided by McMaster
University library we searched conferences and proceed-
ings from January 1993 to December 2012 [11].
Inclusion criteria
Eligibility criteria included all of the following: 1) design -
parallel groups RCTs (cross-over or quasi-randomized
trials were not eligible); 2) population - critically ill adult
patients in the ICU who received enteral nutrition supple-
mentation through a tube or feeding device; trials includ-
ing acute pancreatitis were eligible if the patients were
admitted to the ICU or if they exclusively included
patients with severe acute pancreatitis (severe pancreatitis
should include at least one organ dysfunction or a vali-
dated tool used to define this population); 3) intervention
- post-pyloric feeding (duodenal or jejunal feeding) com-
pared with gastric feeding strategy (trials using percuta-
neous gastrostomy or jejunostomy tubes were not
eligible); and 4) outcomes - primary outcome was pneu-
monia (including ventilator-associated, nosocomial, or
aspiration pneumonia). Secondary outcomes included:
mortality; ICU length of stay; duration of mechanical ven-
tilation (DMV); GI bleeding; aspiration defined as suction-
ing of feeds through airways or endotracheal tube or
documented aspiration through other techniques (e.g.
radioisotope scanning, video fluoroscopy, or dye test);
vomiting defined as ejection of feeds through the oral
cavity; and nutritional outcomes (including daily caloric
intake, proportion of patients achieving target caloric
requirements, and time to achieve goal rate). We did not
apply any language restrictions.
In duplicate and independently, two of three
reviewers selected articles by examining titles and
abstracts and then full text after identifying potentially
relevant articles. Agreement was assessed using kappa
statistic [12].
Data extraction and quality assessment
In duplicate and independently, two reviewers abstracted
data on the design, population, intervention, compari-
son, and clinical outcomes. We wrote to authors to clar-
ify or obtain missing data.
In duplicate and independently, two reviewers assessed
the risk of bias of individual trials using the Cochrane risk
of bias tool. For each outcome in each included trial, the
risk of bias was reported as ‘low risk’, ‘unclear risk’, or
‘high risk’ in the following domains: random sequence
generation; allocation concealment; blinding of partici-
pants and personnel; blinding of outcome assessment;
incomplete outcome data; selective reporting; or other
bias [13]. For each of the outcomes, we independently
rated the overall quality of evidence and confidence in
effect estimates using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
approach in which randomized trials begin as high-quality
evidence, but may be rated down by one or more of five
categories of limitations: risk of bias, inconsistency, indir-
ectness, imprecision, and publication bias [14]. Disagree-
ment was resolved by discussion and consensus.
Data synthesis and analysis
We combined data from all trials to estimate the pooled
risk ratio (RR) and associated 95% confidence intervals
(CI) for all binary outcomes. Weighted mean difference
(WMD) was used to summarize the effect measure for
continues outcomes. Pooled RRs were calculated using
random effects models, applying inverse variance weight-
ing, and the methods of DerSimonian and Laird [15].
Statistical heterogeneity was assessed by the I² statistic
[16]; we interpreted substantial heterogeneity as an I² of
more than 50%.
To address any observed heterogeneity associated with
the effect of small bowel feeding, and to test the robust-
ness of the data, we planned three a priori sensitivity
analyses: excluding studies that did not provide defini-
tion of the outcome, using odds ratio (OR) to summar-
ize the results, and excluding studies that strictly
included patients with severe acute pancreatitis.
The number needed to treat (NNT) was estimated
based on a 15% assumed control risk (ACR) for pneumo-
nia or VAP; this was based on available literature [17,18].
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Publication bias was assessed visually using funnel plot
and statistically using the Egger test [19].
Results
Trial identification
Of 959 citations, 35 full-text articles were assessed for
eligibility and 16 were excluded (Figure 1). Overall, 19
fully published RCTs [10,20-37], were included in the
quantitative and qualitative analysis. We did not identify
any eligible abstracts. We translated one article that was
published in Chinese [28]. Agreement on article inclu-
sion after full-text assessment was excellent (kappa 1.0).
Trial characteristics
In Table 1 we describe characteristics of the included
trials. Trials included a wide range of critical illnesses
with patients in medical, surgical, and trauma ICUs.
Three trials included only patients with severe acute pan-
creatitis [32,35,36]. In one of these trials, not all patients
were admitted to the ICU but due to inclusion of severe
pancreatitis patients with a mortality rate of 25% we
decided to include it [32]. Nine trials investigated the use
of jejunal feeding tubes [10,20,26,28,30-32,35,36] and six
the use of duodenal feeding tubes [21,23-25,33,34],
whereas the rest did not specify the location of the
feeding tube in the small intestine [22,27,29,37]. VAP
preventive strategies were not described consistently in
the included studies. Seven trials clearly reported eleva-
tion of the head of the bed in both groups [22-25,
30,33,37]; other VAP preventive measures were not
reported. The use of prokinetic agents were allowed in
most trials. Although one trial compared gastric feeding
in combination with erythromycin with small bowel feed-
ing alone [29], we included this trial because it only
reported mortality and nutritional outcome, which are
unlikely to be influenced by the use of erythromycin.
Risk of bias
Funnel plot (Figure 2) did not suggest the presence of
publication bias; this was confirmed statistically using
the Egger test (Egger: bias = 0.12; 95% CI = 1.05 to 1.30;
P = 0.82).
In Figure 3, we report methodologic quality assess-
ment using the Cochrane risk of bias tool for each trial.
Overall, five studies were judged to be at low risk of
bias, 13 at high risk of bias, and one had an unclear risk
of bias. We considered a lack of blinding to be of low
effect on mortality outcome; hence the risk of bias was
considered low for this outcome. However, lack of
blinding could introduce performance or ascertainment
bias when assessing other less objective outcomes (e.g.
pneumonia), so the risk of bias was considered to be
high in this setting.
Pooled outcomes
Nosocomial pneumonia
A total of 12 RCTs [10,20-23,26,30,31,33-35,37] includ-
ing 994 patients reported pneumonia as an outcome.
The pooled estimate across trials suggested that the use
of small bowel feeding reduces the risk of pneumonia
(RR = 0.70; 95% CI = 0.55 to 0.90; P = 0.004; I2 = 0%).
The NNT is 17 for ACR 15% (Figure 4).
Ventilator-associate pneumonia
Eight RCTs [10,21,22,26,30,33,34,37] with 835 patients
reported pneumonia in ventilated patients as an outcome.
Small bowel feeding was associated with a lower risk of
VAP (RR = 0.68; 95% CI = 0.53 to 0.89; P = 0.005; I2 =
0%). The NNT is 21 for ACR of 15% (Figure 5).
Mortality
Fifteen RCTs [10,20-22,24,26,29-37] with 1232 patients
reported mortality as an outcome. There was no differ-
ence in mortality between both groups (RR = 1.08; 95%
CI = 0.90 to 1.29; P = 0.43; I2 = 0%; Figure 6).
ICU length of stay
Eight RCTs [10,20,22,26,30,31,33,34] that included 762
patients reported ICU length of stay as an outcome
(Figure 7). There was no difference in days of stay in the
ICU between both groups (WMD = -0.57; 95% CI = -1.79
to 0.66; P = 0.37; I2 = 0%; Figure 7).
Figure 1 Summary of evidence search and selection . Flow
diagram showing steps of study selection.
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Table 1 Characteristics of included trials





Adult critically ill patients; mechanically
ventilated patients in medical and surgical
ICUs
Mean age: 48 years
Males: 60%
Mean APACHE II score: 23
NJ (n = 19)
NG (n = 19)
12 French tube
Endoscopic placement
New or persistent infiltrate on CXR for at least
5 days with any three of the following:
a) purulent sputum with >25 WBC and <10
squamous epithelial cells on Gram stain and
numerous bacteria
b) purulent sputum with >25 WBC and <10
squamous epithelial cells on Gram stain and
nosocomial or respiratory isolates on culture
c) temperature > 38.6 ºC




Adult patients with major trauma and injury
severity score ≥16 and mechanically
ventilated for at least 48 hours
Mean age: 34 years
Male: 77.5%
Mean APACHE II score: 18
Prokinetics not allowed for the first 24
hours
ND or OD (n = 37)
NG or OG (n = 43)
Fluoroscopic insertion
New infiltrate on radiograph (assessed by a
blinded radiologist) of more than 48 hours’
duration and at least two of the following:
a) temperature >38.5 ºC or <35 ºC.
b) blood WBC >10,000/cm3 or <3000/cm3.
c) purulent sputum or isolation of pathogenic
bacteria from endotracheal aspirate. A
radiographic infiltrate and positive quantitative





Adult patients admitted to medical ICU and
mechanically ventilated
Mean age: 51 years
Male: 68%
Mean APACHE II score: 21
All patients received H2 antagonists
Post pyloric (n = 21)
NG (n = 23)
Insertion was assisted using
metoclopramide and tactile cues
Location confirmed radioraphically
(with or without barium)
Presence of a new infiltrate on a chest
radiograph (assessed by 2 pulmonologists) in
the presence of two of the following:
a) WBC >10,000/mm3;
b) temperature >38.5°C; and
c) a positive glucose test or blue discoloration




Adult patients who were admitted to ICU
Mean age: 48 years
Males: 45%
Mean APACHE II score: 16.5
Mechanically ventilated: 79 (99%)
Post pyloric (n = 40)
NG (n = 40) and erythromycin 200 mg
iv every 8 hours for 96 hours
Blind insertion/fluoroscopy in 4
patients




Adult patients in medical ICU
Mean age: 47 years
Male: 68%
Mean APACHE II score: 16
All patients were mechanically ventilated
except 1 patient in the post-pyloric feeding
group and 2 patients in the gastric feeding
group
ND (n = 27)
NG (n = 27)
Blind insertion or fluoroscopy (6
patients)
Position confirmed with EMG and
radiographs




Adult patients admitted to the neuro-ICU
who are expected to receive enteral
feeding for at least 72 hours
Mean age: 57 years
Male: 56%
Mean APACHE III score: 47.8
ND (n = 13)
NG (n = 11)
10-French tube
Blind insertion or fluoroscopy





Adult ICU patients expected to remain
mechanically ventilated for > 72 hours
Mean age: 59 years
Male: 58%
Mean APACHE II score: 22
ND (n = 12)
NG (n = 21)
12 French tubes
Blind/endoscopic insertion
Position confirmed radiologically with/
without contrast





Mean age: 55 years
Male: 70%
Mean APACHE II score: 20
Mechanically ventilated patients: 90%
NJ (n = 34)
NG (n = 39)
Endoscopic insertion






Adult mechanically ventilated patients in
the ICU who are anticipated to require
feeding >5 days
Mean age: 57 years
Male: 73%
Mean APACHE II score: 18
NJ (n = 50)
NG (n = 51)
Blind insertion/endoscopy/fluoroscopy/
echography
CDC criteria for VAP, but no description of the
criteria provided
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Adult patients in the ICU who are
anticipated to require feeding >5 days
Mean age: 57 years
Male: 50%
Mean APACHE II score: NR
Post pyloric (n = 30)




Pneumonia not an outcome
Clinically significant aspiration defined as new
radiographic chest infiltrate that was
empirically treated with antibiotics or the





Adult patients with severe acute pancreatitis
Median age: 60 years
Male: 53%
Median APACHE II score at day1: 11
Mechanically ventilated patients: 15 (31%)
Patients admitted to ICU: 15 (31%)
NJ (n = 22)
NG (n = 27)
7 or 8 French tubes
Endoscopic insertion




Adult patients with severe acute pancreatitis
as defined by Atlanta criteria
Admitted to ICU
Mean age: 40 years
Males: 83%
Mean APACHE II score: 10
Respiratory failure: 19 (63%)
NJ (n = 14)
NG (n = 16)
Endoscopic insertion





Adult patient in medical ICU and
mechanically ventilated
Mean Age: 68 years
Males: 70%
Mean APACHE II score: 20
ND (n = 59)







Adult mechanically ventilated patients in
the ICU
Median age: 52 years
Males: 52%
Median APACHE II score: 27 (APACHE II
score were significantly different in both
groups)
Post pyloric (n = 50)
NG (n = 54)
Blind insertion with erythromycin
Diagnosis of VAP was based on: new onset
(after 48 hours) of fever, leukocytosis, new
pulmonary infiltrates on chest radiograph,
increased pulmonary secretions, and a clinical





Adult patients with severe TBI requiring
mechanical ventilation
Mean age: 38 years
Males: 86%
Mean APACHE II score: 17
NJ (n = 50)
NG (n = 54)
12 French tube
Radiologic placement





Adult patients with severe craniocerebral
injury
Mean age: 40 years
Males: 63%
Mean APACHE II score: NR
NJ (n = 20)
NG (n = 20)





Adult >16 years old patients admitted to
the ICU, mechanically ventilated >48 hours
and receiving opioid infusion
Mean age: 52 years
Males: 74%
Mean APACHE II score: 20
NJ (n = 91)
NG (n = 89)





Adult patients in medical ICU, and requiring
mechanical ventilation for more than 24
hours
Mean age: 69 years
Males: 71%
Mean APACHE II score: 21
ND (n = 50)
NG (n = 51)
12 French tube
Blind/endoscopic insertion
Confirmation using pH measurement
VAP was diagnosed by two pulmonologists





Adult patients with severe acute pancreatitis
as defined by:
Atlanta criteria, APACHE II > 8 or CT severity
index > 7
All patients were admitted to ICU.
Mean age: 39 years
Males: 68%
Median APACHE II score: 8.2
NJ (n = 39)
NG (n = 39)
Endoscopic placement
Pneumonia was not reported in this study
CDC, Centers for Disease Control; CPIS, Clinical Pulmonary Infection Score; CXR, chest x-ray; EMG, electromyography;NG, nasogastric; NJ, nasojejunal; ND,
nasoduodenal; NR, not reported; VAP, ventilator-associated pneumonia; APACHE, acute physiology and chronic health evaluation; TBI, traumatic brain injury; WBC,
white blood cell.
OD, once daily; CT, computed tomography; OG, oro-gastric; BAL, bronchoalveolar lavage
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Duration of mechanical ventilation
Only three RCTs [20,30,33] with 263 patients reported
DMV as an outcome; there was no difference between
both groups in DMV in days (WMD = -1.01; 95% CI =
-3.37 to 1.35; P = 0.40; I2 = 0%; Figure 8).
Gastrointestinal bleeding
Six RCTs [10,20,28,31,33,34] with 546 patients reported
GI bleeding as an outcome; there was no statistically
significant difference between both groups in the risk of
GI bleeding (RR = 0.89; 95% CI = 0.56 to 1.42; P = 0.64;
I2 = 0%; Figure 9).
Aspiration
Six RCTs [10,22,24,25,27,30] with 472 patients reported
aspiration outcomes. There was no statistically signifi-
cant difference between both groups (RR = 0.92; 95%
CI = 0.52 to 1.56; P = 0.79; I2 = 0%; Figure 10).
Vomiting
Six RCTs [10,20,21,25,26,33] with 553 patients reported
vomiting as an outcome. There was no statistically sig-
nificant difference between both groups (RR = 0.91; 95%
CI = 0.53 to 1.54; P = 0.72; I2 = 57%; Figure 11).
Nutritional requirements
Due to marked variations in reporting of nutritional out-
comes, meta-analysis was not performed. We summarize
the nutritional outcomes of the included trials in Table 2.
Overall seven RCTs [20,22,24,26,30,33,35] reported the
mean daily caloric intake; in four studies the mean caloric
intake was higher in patients receiving small bowel feed-
ing, whereas the other studies did not report significant
difference between groups. Four trials reported the mean
time required to achieve target-feeding rate. Due to varia-
tion in defining this outcome (i.e. time measured after ran-
domization, after initial attempt, or after successful
Figure 2 Funnel plot. Figure visually testing for publication bias by
plotting SE(log[RR]) against relative risk, examining the figure for a
symmetry. j
Figure 3 Risk of bias assessment. Figure showing risk of bias
assessment for each trial using Cochrane risk of bias tool. Green-
colored symbol corresponds to low risk of bias, yellow corresponds
to unclear risk of bias, and red corresponds to high risk of bias.
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Figure 4 Pneumonia. Forest plot comparing small bowel feeding with gastric feeding for pneumonia outcome; results are shown using
random-effects model with relative risk and 95% confidence interval (CI).
Figure 5 Ventilator-associated pneumonia. Forest plot comparing small bowel feeding with gastric feeding for ventilator-associated
pneumonia outcome; results are shown using random-effects model with relative risk and 95% confidence interval (CI).
Figure 6 Mortality. Forest plot comparing small bowel feeding with gastric feeding for mortality outcome; results are shown using random-
effects model with relative risk and 95% confidence interval (CI).
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Figure 7 ICU length of stay. Forest plot comparing small bowel feeding with gastric feeding for ICU length of stay outcome; results are shown
using inverse variance weighting with weighted mean difference (WMD) and 95% confidence interval (CI).
Figure 8 Duration of mechanical ventilation. Forest plot comparing small bowel feeding with gastric feeding for duration of mechanical
ventilation outcome; results are shown using inverse variance weighting with weighted mean difference (WMD) and 95% confidence interval
(CI).
Figure 9 Gastrointestinal bleeding. Forest plot comparing small bowel feeding with gastric feeding for gastrointestinal bleeding outcome;
results are shown using random-effects model with relative risk and 95% confidence interval (CI).
Figure 10 Aspiration. Forest plot comparing small bowel feeding with gastric feeding for aspiration outcome; results are shown using random-
effects model with relative risk and 95% confidence interval (CI).
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insertion of feeding tube) quantitative analysis was not fea-
sible. However, most of these studies report a statistically
significant delay in achieving target-feeding rate in the
small bowel feeding group (Table 2).
Subgroup analyses
Although statistical heterogeneity was not observed
except for vomiting outcome (I2 = 57%), we performed
the a priori subgroup analyses to test the robustness of
the data. There was no subgroup difference in risk of
pneumonia or VAP by location of feeding tube (duode-
nal vs. jejunal), nor by risk of bias (low risk vs. high or
unclear risk of bias). The heterogeneity observed in
vomiting outcome was not explained by our a priori
subgroup analyses.
Sensitivity analyses
Despite a lack of heterogeneity we performed a priori
sensitivity analyzes for primary outcome. First analysis
excluded studies that did not provide a definition of
pneumonia outcome [23], the results remained signifi-
cant (RR = 0.71; 95% CI = 0.55 to 0.90; P = 0.004; I2 =
0%). A second analysis used OR as a measure of treat-
ment effect, the results remained statistically significant
(OR = 0.61; 95% CI = 0.39 to 0.97; P = 0.006; I2 = 0%).
A third planned sensitivity analysis excluded studies that
included patients with severe pancreatitis; only one
study reported pneumonia [35] and after excluding this
study the results remained statistically significant (RR =
0.69; 95% CI = 0.50 to 0.96; P = 0.004; I2 = 0%).
Overall summary of findings
We summarize the overall quality of evidence for each
outcome in Table 3. Using GRADE criteria the quality
of evidence was judged to be ‘high’ for mortality and
ICU length of stay outcomes; ‘low’ for pneumonia,
DMV, and GI bleeding outcomes; and ‘very low’ for
aspiration and vomiting outcomes. The main reasons for
lowering the quality of evidence for most outcomes were
risk of bias and imprecision (Table 3).
Discussion
In this systematic review we found that in critically ill
patients small bowel feeding reduces pneumonia
(including VAP) when compared with gastric feeding,
without affecting mortality, ICU length of stay, duration
of mechanical ventilation, or risk of GI bleeding.
The mechanism by which small bowel feeding could
reduce pneumonia risk is not entirely clear. It has been
presumed that the increased gastric volume leads to
regurgitation and aspiration, yet multiple studies have
demonstrated no relation between the GRV and the risk
of aspiration [5,38]. Indeed, the risk of VAP is not
increased when the GRV is not monitored [5]. These
facts question the association between gastric feeding
and the risk of pneumonia. In our meta-analysis we did
not find a significant difference in the risk of clinically
detected aspiration of feeds or vomiting. Only six of 19
eligible trials reported these outcomes, and using
GRADE criteria the quality of evidence for those out-
comes was judged to be very low. Moreover, there was
variation in the definition and methods used for detect-
ing aspiration; these limitations minimize any inferences
we can make based on these outcomes.
Over the past decade four systematic reviews were pub-
lished on this topic, and seemingly reached conflicting
results. Two suggested that small bowel feeding reduces
the risk of pneumonia [6,9] whereas the other two did
not [7,8]. This discrepancy in conclusion could be related
to differences in search strategies, inclusion criteria, or
outcome definition. In the one study the outcome aspira-
tion of feeds and pneumonia were combined as a single
outcome, which attenuated the effect on pneumonia [8].
The most recent and comprehensive review by Jiyong et
al [9] included 966 patients from 15 RCTs suggested that
small bowel feeding reduces the risk of pneumonia in cri-
tically ill patients. However, this review combined the
results of pediatric and adult trials; it did not include
other clinically important outcomes (e.g. mortality, ICU
length of stay, or GI bleeding) and did not assess the
quality of evidence; and two larger RCTs were published
Figure 11 Vomiting. Forest plot comparing small bowel feeding with gastric feeding for vomiting outcome; results are shown using random-
effects model with relative risk and 95% confidence interval (CI).
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after this review [10,34]. Hence, we conducted this
updated systematic review hoping to resolve the ongoing
controversy in the literature. In Table 4 we summarize
the major characteristics and results of prior systematic
reviews in comparison with our review.
One major limitation in the literature is the variation in
reporting and assessing nutritional outcomes among stu-
dies; hence, we only were able to qualitatively describe
the data. Small bowel feeding was either similar or super-
ior to gastric feeding in the amount of calories delivered
per day. However, few studies reported that small bowel
feeding resulted in significant delay of achieving targeted
feeding goals. This is due to longer time required for
insertion of small bowel feeding tubes.
Although the insertion of small bowel feeding tube
appears to be safe, in one study [32] a patient developed
cardiac arrest requiring cardiopulmonary resuscitation
occurring during endoscopic insertion of jejunal tube.
Fortunately, this is an extremely rare event and was not
reported in other trials. However, insertion of small
bowel feeding tubes may be technically challenging. We
report the proportion of failed tube insertion in both
Table 2 Nutritional outcomes
Trial Nutritional assessment outcomes
Outcome Small bowel Gastric
Montecalvo et al. 1992 [20] Volume of feeding delivered (mean, SD)
Mean calories delivered per day (Mean, SD)
Daily goal caloric intake (Mean, SD)
(1209 +/- 344 ml/
day)
(1466 +/- 398 Kcal/
day)
(61 +/- 17%)
(963 +/- 525 ml/day)*
(1182 +/- 603 Kcal/day)*
(46.9 +/- 25.9%)*
Kortbeek et al. 1999 [21] Time to tolerate full feeds (mean, SD) 34 +/- 7.1 hours 43.8 +/- 22.6 hours*
Kearns et al. 2000 [22] Daily calories (mean, SEM)
Daily calories (mean, SEM)
Proportion of energy delivered (mean, SEM)
18 +/- 1 kcal/Kg/
day
1157 +/- 86 Kcal/
day
69 +/- 7%
12 +/- 2 kcal/Kg/day*
812 +/- 122 Kcal/day*
47 +/- 7% *
Boivin and Levy 2001 [29] Time to achieve goal rate (mean) 33 hours 32 hours
Esparza et al. 2001 [24] Average daily percentage of goal feeding 66% 64%
Day et al. 2001 [23] Protein intake (mean, SD)
Delivered calories at day 10 (Mean, SD)
Proportion of delivered calories (Mean, SD)
105 +/- 22g
2147 +/- 625 Kcal
76 +/- 39%
91 +/- 27g
1491 +/- 768 Kcal
86 +/- 23%
Heyland et al. 2001 [25] No nutritional outcomes reported N/A N/A
Davies et al. 2002 [31] Time to start feeds (mean, SEM) 81.2 +/- 13.4 hours 54.4 +/- 4.9 hours
Montejo et al. 2002 [26] Daily caloric intake (mean, SD) 1286 +/- 344 kcal/
day
1237 +/- 342 kcal/day
Neumann and DeLegge
2002 [27]
Time to start feeding from initial attempt
(mean, SD)
27 +/- 22.6 hours 11.2 +/- 11 hours*
Eatock et al. 2005 [32] No difference in time to start feeding between groups N/A N/A
Kumar et al. 2006 [35] Serum pre-albumin (Mean, SD)
All patients achieved the goal of 1800 Kcal within 7 days of feeding
start (no difference)
11.10 +/- 5.28 mg/
dL
17.55+/-4.50 mg/dL (P =
0.002)
Hsu et al. 2009 [33] Daily caloric intake (Mean, SD)
Time to goal rate (Mean, SD)
Proportion of daily goal calorie feeds (Mean, SD)
27.1 +/- 7.6 Kcal/
Kg/day
32.4 +/- 27.1 hours
95 +/- 5%
23.5 +/- 8.8 Kcal/Kg/day*
54.5 +/- 51.4 hours*
83 +/- 6%*
White et al. 2009 [37] Average daily energy deficit (median, IQR)







Proportion of mean efficacious volume 92 +/- 7% 84 +/- 15%*
Zeng et al. 2010 [28] No nutritional outcomes reported. N/A N/A
Davies et al. 2012 [10] Daily energy delivered, (mean, SD)
Proportion of energy requirement delivered for study period (mean,
SD)
1497 +/- 521 Kcal
72% +/- 21%
1444 +/- 485 Kcal
71% +/- 19%
Huang et al. 2012 [34] Proportion of energy intake (mean, SD) 90.4 +/- 20.5% 76.2 +/- 24.9%*
Singh et al. 2012 [36] No nutritional outcomes reported. N/A N/A
P<0.05
SD, standard deviation; SEM, standard error of the mean; IQR, interquartile range; N/A, not available.
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groups. Eight trials clearly reported failure of feeding
tube insertion; overall, there were more failures with
small bowel tube insertion (7% vs. 0%), especially with
blind insertion technique. This highlights the impor-
tance of training of health care professionals to increase
success rate and to avoid delays in starting nutritional
support. The presence of backup methods (e.g. fluoro-
scopic or endoscopic insertion) is thus important,
although not always available. On a practical level, if the
feeding tube does not reach the small bowel the alterna-
tive of feeding into the stomach is available.
There are several strengths of our meta-analysis includ-
ing comprehensive search strategy, multiple clinically
important outcomes, inclusion of non-English trials,
duplicate abstraction, a priori subgroup and sensitivity
analyses, obtaining missing data from authors, and adher-
ence to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [39].
However, there are major limitations of the existing data
that lowers our confidence in the observed treatment
effects. First, the included trials were small in size that
could have biased the overall estimate of treatment effect
- a recent study by Zhang et al [40] looked at the effect of
small sample size on the estimates of mortality outcome
in meta-analyses published in the critical care field and
found that meta-analyses of studies with small sample
size are more likely to be associated with larger treatment
effect independent of methodologic quality of these stu-
dies. They used a cut off of 200 patients per study to
define small size studies, which is larger than any study
included in this meta-analysis. Second, the VAP preven-
tion measures were not reported in most trials, and it is
difficult to ascertain if they were applied, especially that
most included trials were conducted prior to recent
Table 3 Summary of findings























258 per 1000(1000 to 309) RR 1.08 (90
to 1.29)
1232(15 studies) ⊕⊕⊕⊕high
ICU length of stay N/A The mean ICU length of stay in the intervention groups was
0.057 lower(1.79 lower to 0.66 higher)




N/A The mean duration of mechanical ventilation in the
intervention groups was 1.01 lower(3.37 lower to 1.35
higher)
N/A 263(3 studies) ⊕⊕⊝⊝low1,3
GI bleeding 116 per
1000






87 per 1000(49 to 156) RR 0.92
(0.52 to
1.65)
472(6 studies) ⊕⊝⊝⊝very low1,4
Vomiting 228 per
1000





*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on
the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI, confidence interval; GI, gastrointestinal; RR, risk ratio.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1 downgraded for risk of bias, most studies did not blind outcome assessors
2 downgraded for imprecision, total number of events is less than 200
3 downgraded for imprecision 95% CI ranged from - 3.35 to 1.35
4 downgraded for imprecision by 2 points, only 40 events in total and 95% CI ranged between 0.52 to 1.65
5 downgraded for inconsistency I2 = 57%
6 downgraded for imprecision, only 105 events in total
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advances in VAP prevention. This may limit the general-
izability of the results to current patients in whom appli-
cation of VAP preventive strategies is the standard of
care. Third, the definition of pneumonia and VAP were
not consistent across trials. Although the optimal defini-
tion of VAP is controversial [41], the lack of standardized
definition and the difficulty of blinding render the results
susceptible to ascertainment bias. These limitations and
other are reflected in low-quality evidence for pneumonia
outcome (Table 3) and should be considered when inter-
preting the results of this meta-analysis.
Conclusions
Although the use of small bowel feeding as opposed to
gastric feeding appears to reduce the risk of pneumonia
including VAP in critically ill patients, these observa-
tions are limited by several factors and need to be inter-
preted with caution. Small bowel feeding did not affect
other clinically important outcomes. Insertion of small
bowel feeding tube appears to be safe but technically
more challenging than gastric tubes insertion, and may
require radiologic or endoscopic assistance. In our
opinion before implementing this intervention in routine
practice more information is required.
Key messages
• Literature surrounding small bowel feeding in criti-
cally ill patients is ambiguous, with few meta-analyses
reaching opposing conclusions; there were variation in
inclusion criteria, outcome detention, and methodology
that lead to the discrepancy of results.
• A recent RCT suggested that small bowel feeding
does not reduce the risk of VAP in critically ill patients.
• This systematic review and meta-analysis of RCTs
suggests that small bowel feeding is associated with sig-
nificant reduction in risk of pneumonia compared with
gastric feeding. The effect on other clinically important
outcomes was not statistically significant.
Additional material
Additional file 1: Search strategy and excluded references. Contains
electronic database search strategy (search terms) and reference list of all
excluded full-text articles that were assessed for eligibility.
Table 4 Comparison with prior meta-analyses






10 (576) 9 (522) 11 (637) 15 (966) 19 (1394)










































0.76 (0.59, 0.99) 1.44 (0.84, 2.46) a
in favor of small bowel
feeding
1.28 (0.91, 1.80) b
in favor of small bowel
feeding
0.63 (0.48, 0.83) 0.70 (0.55,
0.90)
Comments Different methods in data abstraction, and
inclusion of studies with multiple
interventions that should be excluded
Aspiration events was
analyzed as pneumonia in
one of the studies
Combined pneumonia








a Odds ratio (95% CI)
b Aspiration and pneumonia analyzed as single outcome
CI, confidence interval; DMV, duration of mechanical ventilation; GI, gastrointestinal; LoS, length of stay; RCT, randomized controlled trial; RR, risk ratio.
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